Liver Diseases  >>  TG 4040  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TG 4040 / Transgene
NCT00449124: TG4040 in Patients With Chronic HCV

Withdrawn
1
0
US
Placebo, TG4040
National Institute of Allergy and Infectious Diseases (NIAID)
Hepatitis C
09/07
09/07
NCT00529321: Immunotherapy With TG4040 in Treatment-naïve Patients Chronically Infected With Hepatitis C Virus

Completed
1
42
Europe
MVA-HCV (Immunotherapy)
Transgene
Hepatitis C, Chronic
09/09
09/10

Download Options